Skip to content

MBCT for DM Distress: a Pilot Qusai-experimental Study

Mindfulness-based Cognitive Therapy (MBCT) for Type II Diabetes Mellitus (DM) Patients With High Diabetes Distress and Suboptimal DM Control: a Pilot Qusai-experimental Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03484689
Enrollment
20
Registered
2018-04-02
Start date
2018-07-14
Completion date
2018-11-30
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes-related distress, Mindfulness

Brief summary

Background: Diabetes-related distress (DRD) is very common among people with type II diabetes mellitus (DM). DRD led to poorer DM control and may led to adverse prognosis. Yet, there is no widely accepted or recommended DRD treatment. Mindfulness was shown to relieve psychological distress in various physical and mental conditions. Aim: as a pilot project, we aim to determine if mindfulness-based cognitive therapy (MBCT), which is one of the widely used mindfulness program, is feasible and acceptable and may improve DRD in our Chinese population. Method: 20 Chinese participants with suboptimally controlled DM and high DRD will be recruited to a 8- week MBCT group. Pre-group and post-group (immediate and 2-month post-group) data including DRD score, quality-of life measures will be compared.

Interventions

BEHAVIORALMindfulness-based cognitive therapy MBCT

8-week mindfulness-based cognitive therapy

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* received a clinical diagnosis of type II DM * aged \>=18 * can provide valid consent * can speak Cantonese * can read and write simple Chinese * HbA1c \>7% * have CDDS score \>=3

Exclusion criteria

* diagnosed active mental illness * have severe hearing loss * non-Chinese * have active suicidal ideation as screened by Q9 of PHQ-9 * unwilling to join at least 6 out of 8 session of MBCT * received mindfulness training in the past year or having regular mindfulness practice * received psychotherapy last year * severe physical illness limiting them from coming repeatedly to the group

Design outcomes

Primary

MeasureTime frameDescription
Rate of recruitmentFrom recruitment (1 April) till 20 patients are recruited (within 1 month)As a pilot study, we like to determine if it is feasible to recruit the target patients and measure the relevant outcomes. The number of patient approached and the number of patient recruited will be recorded
Dropout rateWeek 1 (start of MBCT, intervention) till week 8The proportion of patients attending at least 6 out of 8 classes

Secondary

MeasureTime frameDescription
Chinese Version of Diabetes Distress Scale (CDDS-15)At pre-group (week1), immediate post-group (week8) and 2 months post-group (week16)A scale to diagnose and monitor Diabetes Related Distress. The scale ranged from score 0 to 6. The higher the score, the higher the distress.
9-item patient Health Questionnaire (PHQ-9)At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16)A scale of depression score. Higher scores signifies more severe depression. Possible score ranged from 0-27
The Audit of Diabetes-Dependent Quality of Life (ADDQOL)At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16)A measure of Diabetes specific quality of life. The possible score for each domain is from -9(most negative impact of diabetes) to +3 (most positive impact of diabetes). Domains include leisure work, journey, holiday, physical, family life, friendships and social life, personal relationship, sex life, physical appearance, self-confidence, motivation, reactions of other people, feelings about future, financial situation, living conditions, depend on others, freedom to eat, and freedom to drink. The total score is the weighted average of all the domain, so the total score also ranged from -9 to +3.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026